167 related articles for article (PubMed ID: 20398727)
1. EGF receptor activation by GPCRs: an universal pathway reveals different versions.
Liebmann C
Mol Cell Endocrinol; 2011 Jan; 331(2):222-31. PubMed ID: 20398727
[TBL] [Abstract][Full Text] [Related]
2. Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells.
Zou H; Thomas SM; Yan ZW; Grandis JR; Vogt A; Li LY
FASEB J; 2009 Feb; 23(2):425-32. PubMed ID: 18832597
[TBL] [Abstract][Full Text] [Related]
3. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer.
Bhola NE; Grandis JR
Front Biosci; 2008 Jan; 13():1857-65. PubMed ID: 17981673
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Suzuki S; Ishikawa K
Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
[TBL] [Abstract][Full Text] [Related]
8. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors.
Ohtsu H; Dempsey PJ; Eguchi S
Am J Physiol Cell Physiol; 2006 Jul; 291(1):C1-10. PubMed ID: 16769815
[TBL] [Abstract][Full Text] [Related]
9. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways.
Hart S; Fischer OM; Prenzel N; Zwick-Wallasch E; Schneider M; Hennighausen L; Ullrich A
Biol Chem; 2005 Sep; 386(9):845-55. PubMed ID: 16164409
[TBL] [Abstract][Full Text] [Related]
10. EGFR signal transactivation in cancer cells.
Fischer OM; Hart S; Gschwind A; Ullrich A
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1203-8. PubMed ID: 14641026
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
Ansell A; Jedlinski A; Johansson AC; Roberg K
J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
[TBL] [Abstract][Full Text] [Related]
12. Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy.
Berstad MB; Cheung LH; Berg K; Peng Q; Fremstedal AS; Patzke S; Rosenblum MG; Weyergang A
Oncogene; 2015 Oct; 34(44):5582-92. PubMed ID: 25684137
[TBL] [Abstract][Full Text] [Related]
13. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
15. PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells.
Aasrum M; Tjomsland V; Thoresen GH; De Angelis PM; Christoffersen T; Brusevold IJ
J Oral Pathol Med; 2016 Jul; 45(6):425-32. PubMed ID: 26602326
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation.
Hsu JY; Chang KY; Chen SH; Lee CT; Chang ST; Cheng HC; Chang WC; Chen BK
Oncotarget; 2015 Jan; 6(3):1723-39. PubMed ID: 25595899
[TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines.
De Pauw I; Wouters A; Van den Bossche J; Deschoolmeester V; Baysal H; Pauwels P; Peeters M; Vermorken JB; Lardon F
Cancer Biother Radiopharm; 2017 Sep; 32(7):229-238. PubMed ID: 28910149
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation.
Thomas Koch D; Pickhard A; Gebel L; Buchberger AMS; Bas M; Mogler C; Reiter R; Piontek G; Wirth M
Oncotarget; 2017 May; 8(20):32668-32682. PubMed ID: 28427242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
